Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Insulin Resistance in Hepatitis C Infected Thalassemia Children and Survivors of Childhood Malignancy

NCT07238530 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07238530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07238530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Insulin Resistance in Hepatitis C Infected Thalassemia Children and Survivors of Childhood Malignancy
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
September 30, 2015
Completion date
July 1, 2016
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

this study is to assess occurence of insulin resistance among hepatits c infected children whether thalassemic or survivors of childhood malignancy